Bioray Biotech Co., Ltd (TPEX:7561)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
23.00
-0.60 (-2.54%)
Mar 10, 2026, 11:23 AM CST

Bioray Biotech Revenue

Bioray Biotech had revenue of 114.14M TWD in the half year ending June 30, 2025, with 21.35% growth. This brings the company's revenue in the last twelve months to 230.06M, up 25.32% year-over-year. In the year 2024, Bioray Biotech had annual revenue of 201.71M with 5.15% growth.

Revenue (ttm)
230.06M
Revenue Growth
+25.32%
P/S Ratio
3.03
Revenue / Employee
n/a
Employees
n/a
Market Cap
698.21M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024201.71M9.88M5.15%
Dec 31, 2023191.83M1.23M0.65%
Dec 31, 2022190.60M42.58M28.77%
Dec 31, 2021148.02M-8.28M-5.30%
Dec 31, 2020156.30M-25.64M-14.09%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
General Biologicals 251.38M
Prince Pharmaceutical 798.27M
Mediera 229.85M
Original BioMedicals 381.00K
Anxo Pharmaceutical 883.22M
UniPharma 90.79M
Excelsior Biopharma 898.26M
DV Biomed 712.61M
Revenue Rankings